P1G10 proteolytic fraction from V. cundinamarcensis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for P1G10 proteolytic fraction from V. cundinamarcensis, covering 2018-10-10 to 2018-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer [Phase 2]